$19.00
Manufacturer: Hungary
Aurobin (prednisolone capronate) is used for processes accompanied by inflammation of the perianal area: itching, eczema and dermatitis.
Out of stock
Description
Ingredients
active ingredients: prednisolone capronate, lidocaine hydrochloride, dexpanthenol;
1 g of ointment contains prednisolone capronate 2 mg, lidocaine hydrochloride 20 mg, dexpanthenol 20 mg;
excipients: polysorbate 60, triclosan, methyl paraben (E 218), cetyl alcohol, glycerin, propylene glycol, polyethylene glycol stearate, mineral oil, dimethicone, medium chain triglycerides, stearic acid, purified water.
Dosage form
Ointment.
Basic physical and chemical properties: homogeneous ointment of white or almost white color, practically odorless.
Pharmacotherapeutic group
Means for the treatment of hemorrhoids and anal fissures for local use. Code ATX C05A X03.
Pharmacodynamics
Aurobin is a combined preparation, which contains substances in the optimal ratio that are effective in the treatment of inflammatory processes and pain in the perianal region.
Prednisolone capronate is a non-halogenated corticosteroid with a local anti-inflammatory effect. It reduces the permeability of blood vessels, increases the tone of the walls of blood vessels, reduces the symptoms of inflammation.
Lidocaine relieves pain and burning sensation in a short time.
Dexpanthenol promotes the regeneration of damaged epithelium and mucous membranes.
Indications
Processes accompanied by inflammation of the perianal area: itching, eczema and dermatitis of the perianal area, hemorrhoids, anal fissures.
Contraindications
Hypersensitivity (allergy) to one of the active ingredients of the drug or to any of the excipients of the drug.
Hypersensitivity to other local anesthetics of the amide type (eg bupivacaine, etidocaine, mepivacaine and prilocaine).
Treatment of the eye or periocular area.
Primary bacterial, viral or fungal skin lesions, including herpes simplex.
Acne rosacea on the face, acne vulgaris, perioral dermatitis or diaper rash, skin tuberculosis, skin manifestations of syphilis, dryness, peeling of the skin.
Simultaneous treatment with lidocaine in connection with other indications.
Skin tumors.
Cushing’s syndrome.
period of vaccination.
Age up to 1 year.
I trimester of pregnancy.
Dosage and administration
For external use only.
The use of the ointment for a long time and on a large area of \u200b\u200bthe skin should be avoided, regardless of the age of the patient.
Application under an occlusive dressing is not recommended.
Adults and elderly patients.
A thin layer of ointment is applied to the affected area 2-4 times a day. With a decrease in the manifestation of symptoms, the ointment should be used less frequently. The duration of treatment should not exceed 5-7 days.
Children.
Children over the age of 1 year can use the drug only in exceptional cases, in the minimum dose that ensures the achievement of a therapeutic effect and not more than 2 times a day. The duration of treatment for children should not exceed 5 days.
Recent Reviews